Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ( Beyond Air or the Company ), a commercial stage medical device and biopharmaceutical company focused on...